Floatz logo

Udenafil

Prostate Cancer With Radical Prostatectomy

Samsung Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

514 Active assets in the Prostate Cancer With Radical Prostatectomy cohort.

Asset / SponsorPhaseRating
Avodart
Bay State Clinical Trials, Inc.
Phase 4BBB
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
Degarelix
Bayer
Phase 4BBB
PROPOFOL
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
VIPIVOTIDE TETRAXETAN
Novartis Pharmaceuticals
Phase 4BB

View all 50 →

Same molecule, other indications

Udenafil is also rated in:

rectal carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
erectile dysfunctionDormant
B
Indicative ·
57 / 100
View asset →
sigmoid colon cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →